Baycrest appoints new Chief of Medicine Dr. Gary Naglie

Toronto, Ontario, November 1, 2010 — One of Canada’s leading experts in the care of frail older adults joins Baycrest today as the new Chief of Medicine.

Dr. Gary Naglie brings research leadership in rehabilitation, drug policy and evaluation of programs and interventions for older adults with dementia, Parkinson’s disease, end-stage renal failure, prostate cancer and hip fractures. He is strongly focused on the assessment of quality of life in older adults and identifying the most reliable measurements for it to help inform best treatments.

“We are privileged to have someone of Dr Naglie’s stature join the Baycrest team. His expertise and vision for the future will be critically important over the next several years as we seek to operationalize our strategic objectives,” said Dr. Paul Katz, vice-president, Medical Services and Chief of Staff.

“As Chief of Medicine, Dr Naglie will be at the forefront of further integrating our clinical, research and educational activities to ensure the care we provide at bedside is the very best it can be.”

“I am very excited to be joining such a talented and dynamic organization with a commitment to innovation, excellence and global leadership,” said Dr. Naglie, the first holder of the Mary Trimmer Chair in Geriatric Medicine Research from the University of Toronto, a position he will continue alongside his new role at Baycrest.

Dr. Naglie led a recently completed national study, funded by the Canadian Institutes of Health Research (CIHR) and Alzheimer Society of Canada, to assess quality of life for patients with Alzheimer’s disease and their caregivers. He is the lead researcher on a CIHR-funded study to identify the most reliable predictors of on-road driving capacity in persons with mild cognitive impairment

Dr. Naglie holds Fellowships from the Royal College of Physicians and Surgeons of Canada in internal and geriatric medicine. Prior to joining Baycrest, he was a geriatrician at the University Health Network and the Toronto Rehabilitation Institute (TRI), and a senior scientist with the Toronto General Research Institute and the TRI. He has several affiliations with the University of Toronto, including associate professor in the Departments of Medicine and Health Policy, Management and Evaluation; graduate faculty member at the Institute of Medical Science; and member of the Faculty of Medicine.

Baycrest is a world-class developer of innovations in aging that enhance quality of life by optimizing physical and mental wellbeing. Baycrest is affiliated with the University of Toronto.

– 30 –

For more information on this press release, please contact:
Kelly Connelly
Senior Media Officer